calcium trisodium pentetate

Suppliers

Names

[ CAS No. ]:
12111-24-9

[ Name ]:
calcium trisodium pentetate

[Synonym ]:
Pentetate sodium calcium
CALCIUMDTPA
Pentetate Calcium Trisodium

Chemical & Physical Properties

[ Boiling Point ]:
721.1ºC at 760mmHg

[ Molecular Formula ]:
C14H18CaN3Na3O10

[ Molecular Weight ]:
497.35400

[ Flash Point ]:
389.9ºC

[ Exact Mass ]:
497.03100

[ PSA ]:
182.71000

[ Vapour Pressure ]:
9.53E-23mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MB8210000
CHEMICAL NAME :
Glycine, N,N-bis(2-(bis(carboxymethyl)amino)ethyl)-, calcium trisodium salt
CAS REGISTRY NUMBER :
12111-24-9
LAST UPDATED :
199701
DATA ITEMS CITED :
13
MOLECULAR FORMULA :
C14-H18-N3-O10.Ca.3Na
MOLECULAR WEIGHT :
497.40
WISWESSER LINE NOTATION :
OV1N1VO&2N1VO2N1VO&1VO &-NA- 3 &-CA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2512 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7269 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
659 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1790 mg/kg
SEX/DURATION :
female 9-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
2685 mg/kg
SEX/DURATION :
female 9-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3581 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - eye/ear
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
30 gm/kg
SEX/DURATION :
female 1-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
3580 mg/kg
SEX/DURATION :
female 7-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
TYPE OF TEST :
DNA inhibition

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Rodent - rat Liver
DOSE/DURATION :
10 mmol/L
REFERENCE :
BCPCA6 Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1958- Volume(issue)/page/year: 23,901,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X9954 No. of Facilities: 116 (estimated) No. of Industries: 1 No. of Occupations: 4 No. of Employees: 1702 (estimated) No. of Female Employees: 1258 (estimated)

Related Compounds

  • CALCIUM TRISODIUM DIETHYLENETRIAMINEPENTAACETATE HYDRATE
  • Diethylenetriaminepentaacetic Acid Calcium Trisodium Salt Hydrate
  • Calcium trinatrium diethylenetriaminepentaacetic acid hydrate
  • Calcium Petronate HMW
  • calcium,(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate
  • CALCIUM ACETYLACETONATE HYDRATE
  • 2-[(1RS,3SR)-3-[(2S,3S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylpentanamido]cyclopentyl]acetic acid
  • 1-[({5-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]oxolan-3-yl}formamido)methyl]cyclopropane-1-carboxylic acid
  • rac-(1R,5R,6S)-6-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]acetamido}bicyclo[3.2.0]heptane-3-carboxylic acid
  • 6-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]bicyclo[3.2.0]heptane-3-carboxylic acid
  • 1-{8,8-Difluoro-2,6-diazaspiro[3.4]octan-6-yl}-2-methylpropan-1-one
  • 3-(2-{3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopentyl}acetamido)-2-hydroxypropanoic acid
  • 3-(2-{3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopentyl}acetamido)-2-hydroxy-2-methylpropanoic acid
  • 2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopent-1-ene-1-carbonyl]-5-oxopyrazolidine-3-carboxylic acid
  • 3-{N-cyclopropyl-1-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)phenyl]formamido}propanoic acid
  • rac-2-[(1R,2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexanecarbonyl]-5-oxopyrazolidine-3-carboxylic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.